GC Genome Corporation (KOSDAQ:340450)
South Korea · Delayed Price · Currency is KRW 5,390.00
0.00 (0.00%)
Aug 24, 2026, 3:30 PM KST
GC Genome Market Cap
GC Genome has a market cap or net worth of 127.48 billion as of August 24, 2026. Its market cap has decreased by -30.00% in one year.
Market Cap
127.48B
Enterprise Value
88.72B
Revenue
32.16B
Ranking
n/a
PE Ratio
27.04
Stock Price
5,390.00
ChartMarket Cap Chart
Since June 11, 2025, GC Genome's market cap has decreased from 262.52B to 127.48B, a decrease of -51.44%. That is a compound annual growth rate of -45.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 127.48B | -20.97% |
| Dec 30, 2025 | 161.30B | -38.56% |
| Jun 11, 2025 | 262.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.72T |
| Celltrion | 44.10T |
| ALTEOGEN | 22.28T |
| Samsung Epis Holdings | 8.94T |
| Macrogen | 135.52B |
| Samil Pharmaceutical Co.,Ltd | 132.50B |
| Shinhung | 129.55B |
| HANDOK | 121.73B |